Application
Western blot analysis of ATP6V1A Antibody (Center) in A2058 cell line lysates (35ug/lane). ATP6V1A (arrow) was detected using the purified Pab.Application
ATP6V1A Antibody (Center) IHC analysis in formalin fixed and paraffin embedded breast carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the ATP6V1A Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | ATP6V1A Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | ATP6A1, ATP6V1A1, VPP2 |
|---|---|
| Alternative Names | ATP6V1A ATP6A1 ATP6V1A1 VPP2 V-type proton ATPase catalytic subunit A V-ATPase 69 kDa subunit Vacuolar ATPase isoform VA68 Vacuolar proton pump subunit alpha |
| Molecular Weight(MW) | 68304 Da |
| Function | Catalytic subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase vacuolar ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells |
| Tissue Specificity | Present in all tissues analyzed. |
| Entrez Gene | 523 |
|---|
Application
Western blot analysis of ATP6V1A Antibody (Center) in A2058 cell line lysates (35ug/lane). ATP6V1A (arrow) was detected using the purified Pab.
Application
ATP6V1A Antibody (Center) IHC analysis in formalin fixed and paraffin embedded breast carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the ATP6V1A Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
